These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25553853)

  • 1. Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation.
    Schnitzbauer AA; Ayik C; Ulrich F; Bechstein WO; Mönch C
    Ann Transplant; 2015 Jan; 20():1-6. PubMed ID: 25553853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
    Bäckman L; Persson CA
    Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation.
    de Jonge H; Kuypers DR; Verbeke K; Vanrenterghem Y
    Transplantation; 2010 Sep; 90(5):523-9. PubMed ID: 20592652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of once-daily modified-release tacrolimus in liver transplant recipients: a multicenter postmarketing surveillance in Japan.
    Uemoto S; Abe R; Horike H; So M
    Transplant Proc; 2014 Apr; 46(3):749-53. PubMed ID: 24767340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
    Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe One-to-One Dosage Conversion From Twice-Daily to Once-Daily Tacrolimus in Long-Term Stable Recipients After Liver Transplantation.
    Wu YJ; Lin YH; Yong CC; Li WF; Wang SH; Wang CC; Lin TL; Chen CL; Lin CC
    Ann Transplant; 2016 Jan; 21():30-4. PubMed ID: 26782179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
    Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK
    J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
    Andrés A; Budde K; Clavien PA; Becker T; Kessler M; Pisarski P; Fornara P; Burmeister D; Hené RJ; Cassuto-Viguier E;
    Transplantation; 2009 Nov; 88(9):1101-8. PubMed ID: 19898206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J; Guillaud O; Boillot O
    Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
    Baccarani U; Velkoski J; Pravisani R; Adani GL; Lorenzin D; Cherchi V; Falzone B; Baraldo M; Risaliti A
    Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First clinical experience with the new once-daily formulation of tacrolimus.
    First MR
    Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
    Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
    Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study.
    Kim JM; Kwon CH; Joh JW; Sinn DH; Lee S; Choi GS; Lee SK
    Liver Transpl; 2016 Feb; 22(2):209-16. PubMed ID: 26360125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort.
    Gastaca M; Valdivieso A; Bustamante J; Fernández JR; Ruiz P; Ventoso A; Testillano M; Palomares I; Salvador P; Prieto M; Montejo M; Suárez MJ; de Urbina JO
    Liver Transpl; 2016 Oct; 22(10):1391-400. PubMed ID: 27434676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study.
    Sańko-Resmer J; Boillot O; Wolf P; Thorburn D
    Transpl Int; 2012 Mar; 25(3):283-93. PubMed ID: 22239105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
    Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
    Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
    Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
    Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo Prograf versus de novo Advagraf: are trough level profile curves similar?
    Sarvary E; Wagner L; Telkes G; Gaman G; Varga M; Gaal I; Mathe Z; Chmel R; Fehervari I; Langer RM
    Transplant Proc; 2014; 46(6):2164-7. PubMed ID: 25131131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.